Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
life sciences
national blog main
national top stories
new york blog main
new york top stories
startups
abbvie
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
adverum biotechnologies
akouos
albert bourla
What
ceo
3
×
acquisitions
bio
medicines
roundup
aims
albert
announced
backed
biggest
bourla
cause
collabs
company
covid
crispr
daniel
deal
drug
drugs
epilepsy
future
genes
genetic
gilead
gilead’s
help
imports
introduce
ipo
links
maker
maps
marcio
measured
month
mutations
neuro
new
o’day
Language
unset
unknown
Current search:
biogen
×
ceo
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More